Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

作者：Kohei Shitara, Kei Muro, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Yoshito Komatsu, Tomohiro Nishina, Kensei Yamaguchi, Yoshihiko Segawa, Yasushi Omuro, Takao Tamura, Toshihiko Doi, Seigo Yukisawa, Hirofumi Yasui, Fumio Nagashima, Masahiro Gotoh, Taito Esaki, Michael Emig, Kumari Chandrawansa, Astra M. Liepa, Hansjochen Wilke, Yukako Ichimiya, Atsushi Ohtsu · 发表于：Gastric Cancer · 年份：2015 · DOI：10.1007/s10120-015-0559-z · 被引用次数：87 · 研究领域：Gastric Cancer Management and Outcomes、Esophageal Cancer Research and Treatment、Helicobacter pylori-related gastroenterology studies